» Articles » PMID: 9364006

Dibenzo[a,l]pyrene-induced DNA Adduction, Tumorigenicity, and Ki-ras Oncogene Mutations in Strain A/J Mouse Lung

Overview
Journal Carcinogenesis
Specialty Oncology
Date 1997 Nov 18
PMID 9364006
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Dibenzo[a,l]pyrene (DB[a,l]P), an environmental polycyclic aromatic hydrocarbon, is the most potent carcinogen ever tested in mouse skin and rat mammary gland. In this study, DB[a,l]P was examined for DNA adduction, tumorigenicity, and induction of Ki-ras oncogene mutations in tumor DNA in strain A/J mouse lung. Groups of mice received a single i.p. injection of 0.3, 1.5, 3.0, or 6.0 mg/kg DB[a,l]P in tricaprylin. Following treatment, DNA adducts were measured at times between 1 and 28 days, while tumors were counted at 250 days and analyzed for the occurrence of point mutations in codons 12 and 61 of the Ki-ras oncogene. DB[a,l]P in strain A/J mouse lung induced six major and four minor DNA adducts. Maximal levels of adduction occurred between 5 and 10 days after injection followed by a gradual decrease. DB[a,l]P-DNA adducts in lung tissue were derived from both anti- and syn-11,12-dihydroxy-13,14-epoxy- 11,12,13,14-tetrahydrodibenzo[a,l]pyrene (DB[a,l]PDE) and both deoxyadenosine (dAdo) and deoxyguanosine (dGuo) residues in DNA as revealed by cochromatography. The major adduct was identified as a product of the reaction of an anti-DB[a,l]PDE with dAdo in DNA. DB[a,l]P induced significant numbers of lung adenomas in a dose-dependent manner, with the highest dose (6.0 mg/kg) yielding 16.1 adenomas/mouse. In tricaprylin-treated control animals, there were 0.67 adenomas/mouse. Based on the administered dose, DB[a,l]P was more active than other environmental carcinogens including benzo[a]pyrene. As a function of time-integrated DNA adduct levels, DB[a,l]P induced lung adenomas with about the same potency as other PAHs, suggesting that the adducts formed by DB[a,l]P are similar in carcinogenic potency to other PAHs in the strain A/J mouse lung model. Analysis of the Ki-ras mutation spectrum in DB[a,l]P-induced lung tumors revealed the predominant mutations to be G-->T transversions in the first base of codon 12, A-->G transitions in the second base of codon 12, and A-->T transversions in the second or third base of codon 61, concordant with the DNA adduct profile.

Citing Articles

Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer.

Chiu W, Ou D, Tan C Int J Mol Sci. 2022; 23(16).

PMID: 36012461 PMC: 9409124. DOI: 10.3390/ijms23169195.


Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.

Pande P, Madeen E, Williams D, Crowell S, Ognibene T, Turteltaub K Toxicol Appl Pharmacol. 2021; 438:115830.

PMID: 34933053 PMC: 9264404. DOI: 10.1016/j.taap.2021.115830.


Evaluation of Carcinogenic Polyaromatic Hydrocarbon Levels in Airborne Particulates Associated with Long-Term Exposure throughout the COVID-19 Pandemic in Makkah, Saudi Arabia.

Adly H, Saleh S Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886471 PMC: 8656748. DOI: 10.3390/ijerph182312745.


Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs.

Baiken Y, Kanayeva D, Taipakova S, Groisman R, Ishchenko A, Begimbetova D Front Cell Dev Biol. 2021; 8:617884.

PMID: 33553154 PMC: 7862338. DOI: 10.3389/fcell.2020.617884.


Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma.

Li Q, Dong H, Yang G, Song Y, Mou Y, Ni Y Front Oncol. 2020; 10:212.

PMID: 32158692 PMC: 7052016. DOI: 10.3389/fonc.2020.00212.